Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.380
+0.030 (2.22%)
Dec 20, 2024, 4:00 PM EST - Market closed
Aytu BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 20, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Market Capitalization | 8 | 17 | 9 | 27 | 126 | 171 | |
| Market Cap Growth | -3.00% | 97.32% | -66.79% | -78.89% | -26.16% | 442.34% | |
| Enterprise Value | 7 | 16 | 15 | 20 | 106 | 113 | |
| Last Close Price | 1.38 | 2.92 | 1.60 | 13.80 | 100.20 | 284.00 | |
| PS Ratio | 0.10 | 0.22 | 0.08 | 0.28 | 1.92 | 6.18 | |
| PB Ratio | 0.28 | 0.63 | 0.22 | 0.60 | 0.92 | 1.80 | |
| P/TBV Ratio | - | - | - | - | - | 9.45 | |
| EV/Sales Ratio | 0.08 | 0.20 | 0.14 | 0.21 | 1.61 | 4.10 | |
| EV/EBITDA Ratio | 1.02 | 2.67 | - | - | - | - | |
| Debt / Equity Ratio | 0.61 | 0.59 | 0.47 | 0.41 | 0.18 | 0.02 | |
| Debt / EBITDA Ratio | 2.17 | 1.94 | - | - | - | - | |
| Asset Turnover | 0.64 | 0.64 | 0.78 | 0.48 | 0.31 | 0.29 | |
| Inventory Turnover | 2.06 | 2.09 | 3.57 | 3.41 | 2.77 | 1.45 | |
| Quick Ratio | 0.71 | 0.70 | 0.75 | 0.64 | 0.71 | 1.87 | |
| Current Ratio | 0.99 | 0.99 | 1.03 | 0.93 | 0.96 | 2.62 | |
| Return on Equity (ROE) | -23.48% | -47.24% | -40.76% | -119.62% | -50.12% | -26.68% | |
| Return on Assets (ROA) | -0.72% | -1.06% | -5.62% | -11.81% | -11.41% | -11.91% | |
| Return on Capital (ROIC) | -1.87% | -2.65% | -12.81% | -21.18% | -18.43% | -21.52% | |
| Earnings Yield | -73.65% | -90.85% | -192.92% | -408.69% | -46.22% | -7.98% | |
| FCF Yield | -29.50% | -7.96% | -58.03% | -108.29% | -22.45% | -16.62% | |
| Buyback Yield / Dilution | -39.29% | -65.81% | -127.22% | -75.54% | -270.57% | -479.80% | |
| Total Shareholder Return | -39.29% | -65.81% | -127.22% | -75.54% | -270.57% | -479.80% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.